Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
24 April 2025
Cancers Exceptional Reviewers List 2025
We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cancers (ISSN: 2072-6694) recognizes the significant role that our reviewers play in maintaining the quality and integrity of the articles that we publish. According to surveys conducted in 2024, 92% of our authors rate the peer-review process as good or excellent, which is thanks to our pool of excellent reviewers.
We wish to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist Cancers’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback and contributing to academic rigor, are truly commendable.
The Exceptional Reviewers List was introduced in April 2025. Each quarter, we select a group of outstanding reviewers, and we introduce them here.
Q1
Name: Dr. Mohammad Mofatteh
Affiliation: School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, UK
Interests: neurosurgery; surgery; neuroscience; global health; medical education
“Engaging in peer-review sharpens my critical thinking, keeps me at the forefront of cutting-edge research, and strengthens the scientific community by ensuring rigorous quality assurance. I prioritize delivering constructive feedback to elevate the clarity, validity, and impact of each manuscript.”
Name: Dr. Radu O. Minea
Affiliation: Department of Neurosurgery, Keck School of Medicine, USC, Los Angeles, CA 90089, USA
Interests: cancer biology; apoptosis; cell culture; cell signaling; cancer cell biology; cell proliferation; flow cytometry; gene expression; immunohistochemistry; Western blot analysis
“I have enjoyed working with the editors of the Cancers journal in my past interactions with them and I am committed to help with the peer-review process in the future.”
Name: Dr. Radoslaw Pach
Affiliation: Jagiellonian University Medical College, Krakow, Poland
Interests: oncological surgery; colorectal cancer; gastric cancer; thyroid surgery; hernia; laparoscopy
“I review for journals using my clinical and research expertise to assess oncology studies, focusing on rigor, clarity, and impact, and providing constructive, evidence-based feedback.”
Name: Dr. Giovanni Colonna
Affiliation: Medical Informatics Unit, AOU L. Vanvitelli, University of Campania, Piazzetta Sant’Aniello a Caponapoli 2, 80138 Naples, Italy
Interests: cancer biology; bioinformatics and computational biology; enzymes; proteins; PCR;
protein purification; protein expression; evolution; critical thinking; cancer cell biology
“Cancer research faces significant obstacles in accurately modeling the complexity of human tumors with current preclinical systems. From observational data, we cannot directly obtain the deep molecular causes without specific experimental data.”
Name: Prof. Dr. Lars Martin Wagner
Affiliation: Division of Pediatric Hematology/Oncology, Duke University, Durham, North Carolina
Interests: pediatric sarcoma; young adult sarcoma; clinical trials; sarcoma biology; treatment response; rare cancers; translational research
